58. Hypertrophic cardiomyopathy Clinical trials / Disease details

Clinical trials : 126 / Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05025644 (ClinicalTrials.gov)	March 2023	11/8/2021	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test	Hypertrophic Obstructive Cardiomyopathy	Drug: Pre and post-CPB Drug: Dobutamine Hydrochloride;Drug: Post-CPB Drug: Dobutamine Hydrochloride	University Health Network, Toronto	NULL	Not yet recruiting	18 Years	N/A	All	60	Phase 4	NULL
2	NCT01375335 (ClinicalTrials.gov)	June 2011	14/6/2011	The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement	The Effects of Dobutamine on Postoperative Systolic Deformation and Diastolic Function in Patients With Hypertrophic Cardiomyopathy Operated for Aortic Valve Stenosis	Heart Failure	Drug: Dobutamine	University of Aarhus	NULL	Suspended	19 Years	90 Years	Both	10	Phase 4	Denmark